Subacromial Impingement Syndrome Withdrawn Phase Trials for Ketorolac (DB00465)

IndicationStatusPhase
DBCOND0036420 (Subacromial Impingement Syndrome)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01449448Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement SyndromeTreatment